If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How is Baqsimi™ (glucagon) nasal powder delivered?
Glucagon nasal powder is a dry nasal powder delivered via a ready-to-use nasal dosing device.
Delivery
Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1
Baqsimi is a 3-mg glucagon dry nasal powder. It is delivered via a nasal dosing device that
- is ready to use and requires no reconstitution
- is a compact, portable, single-use, drug-device combination, and
- does not require a person to inhale.1
Enclosed Prescribing Information
References
1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Date of Last Review: November 10, 2021